Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02465567” into the search
box, and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click “Home and Search”, then
type “2014-005671-92” in the search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type “PT010005” into the
search box, and click “Find a Study”.
Full Study Title: A Randomized, Double-Blind, Multi-Center, Parallel-Group Study to Assess
the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a
52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
AstraZeneca Protocol Number: PT010005
National Clinical Trials number: NCT02465567
EudraCT number: 2014-005671-92
Pearl Therapeutics, Inc. sponsored this study and has its headquarters in Redwood City, CA,
USA.
The phone number for the AstraZeneca Information Centre is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part
in clinical research around the world. They help researchers answer important
health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organisation focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109, USA
1-877-MED-HERO • www.ciscrp.org
Version 1.0_2021_11_04 12